ISPE Logo

COMMUNITIES

Overview

SIGs

Councils

Committees

Chapters

Special Interest Group in Vaccines

VAXSIG Webpage Information

Objectives:

  1. To foster development and adoption of methods to improve the accurate and efficient collection of vaccine exposure information (e.g., 2D barcodes, vaccine generic names, vaccine doses and dates of delivery) for each vaccinee.  Lot identifiers, in particular, would allow verification of the exact vaccine product (type and manufacturer) as well as linkage to details of vaccine antigens, preservatives, and excipients).
  2. To foster development and sharing of new/existing methods for vaccine safety, effectiveness, usage, cost-benefit, risk-management/mitigation across the life cycle of vaccines from pre- to post-licensure, and from signal detection to hypothesis testing.
  3. To provide a forum for interaction with regulatory authorities and public health agencies to raise awareness and stimulate incorporation of vaccine specific and relevant aspects into regulations and regulatory templates.
  4. To assist low and middle-income countries with development of their data collection and technical expertise in vaccine pharmacoepidemiology.

Mission:

strives to achieve these goals by offering a platform for interested ISPE members to plan educational activities for the ICPE pre-conference courses together with the education committee, shared national and international projects and grant proposals, and joined presentation in form of workshops, symposia or poster walks at annual ICPE meetings.   Whenever possible, the VAX SIG will seek to maximize synergy with existing vaccine institutions and stakeholders.

Committee Leaders

Chair Harry Seifert, MD, MSCE Clinical Safety Sciences GSK
Pennsylvania, USA
harry.a.seifert@gsk.com
Immediate Past-Chair Bob Chen, MD, MA Division of HIV/AIDS Prevention and Control
CDC
Atlanta, USA
rtc1@cdc.gov
Coordinator James Stark, PhD Worldwide Safety and Regulatory
Pfizer
New York, USA
James.Stark@pfizer.com

Workgroup Leaders

Regulatory Guidance Mendel Haag, PhD Epidemiology
Seqirus
Amsterdam, Netherlands
mendel.haag@seqirus.com
Methodology Patricia Saddier, MD, PhD Pharmacoepidemiology Department
Merck Research Laboratories
Pennsylvania, USA
patricia_saddier@merck.com
Education and Advocacy in Low and Middle Income Countries Andrea Sutherland, MD GSK
Rockville, Maryland, USA
andrea.x.sutherland@gsk.com
Education and Advocacy in Low and Middle Income Countries Daniel Weibel, PhD Daniel Weibel, PhD
Erasmus University Medical Center
Rotterdam, Netherland
d.weibel@erasmusmc.nl

Members

Syed Ahmad
Valentina Attanasi
Steven Bailey
Meghan Baker
Vincent Bauchau
Jorgen Bauwens
Kaat Bollaerts
Jan Bonhoeffer
Bob Brody
Anne Butler
Rebecca Chandler
Bob Chen
Jing Chen
Adam Cui
Caitlin Dodd
Jonathan Duffy
Katherine Duszynski
Germano Ferreira
Bruce Fireman
Vera Frajzyngier
Lourdes Frau
Joanne Gruber
Mendel Haag
Penina Haber
Eelko Hak
Janet Hardy
Kui Huang
Wan-Ting Huang
Chris Jankosky
Judith Jones
Dan Kajungu
Alison Kawai
Alena Khromava
Sonali Kochhar
Martin Kuldorff
Bradley Layton
Andreia Leite
Morgan Marks
David Martin
Mike McNeil
Pedro Moro
Catherine Panozzo
Vitali Pool
Patricia Saddier
Daphne Sawlwin
Harry Seifert
Vivek Shinde
Francois Simondon
James Stark
Miriam Sturkenboom
Andrea Sutherland
Charlotte Switzer
Lina Titievsky
Sylvie Tomczyk
Priscilla Velentgas
Thomas Verstraeten
Daniel Weibel
Lisa Weiss
Yonas Weldeselassie
Heather Whitaker
Corinne Willame
Bob Wise
Katherine Yih
Huifeng Yun
Qusseny Zerbo

Dates of meetings: 

Occurs the first Wednesday of every month at 9:00 am EST (UTC/GMT -5 hours). Interested persons should email James Stark: James.Stark@pfizer.com

Meeting Minutes

April 5, 2017 meeting minutes

February 1, 2017 meeting minutes

January 4, 2017 meeting minutes

December 14, 2016 meeting minutes

November 2, 2016 meeting minutes

October 5, 2016 meeting minutes

September 7, 2016 meeting minutes

August 26, 2016 meeting minutes

Vaccine SIG Board report for August 2016 meeting